Actively Recruiting

Age: 18Years +
All Genders
NCT05536089

ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation

Led by Singlera Genomics Inc. · Updated on 2024-05-22

2000

Participants Needed

1

Research Sites

325 weeks

Total Duration

On this page

Sponsors

S

Singlera Genomics Inc.

Lead Sponsor

S

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborating Sponsor

AI-Summary

What this Trial Is About

In this study, the investigators aimed to apply their previously developed multi-locus blood-based assay targeting circulating tumor DNA methylation to monitor postoperative relapse and evaluate adjuvant chemotherapy efficacy in resected stage I and stage II (without high risk) colorectal cancer after radical resection.

CONDITIONS

Official Title

ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed stage I or stage II (without high risk) colorectal cancer
  • Male or female aged 18 years or older on the day of signing informed consent
  • Positive ctDNA test before colorectal cancer surgery
  • Eastern Cooperative Oncology Group (ECOG) performance status of 1 or less
  • Ability to provide written informed consent and comply with study requirements
Not Eligible

You will not qualify if you...

  • Personal history of colorectal cancer, colorectal adenoma, or aerodigestive tract cancer
  • Received neoadjuvant systemic therapy before colorectal cancer surgery
  • Pregnant or lactating
  • Any condition or abnormality that could affect study results or participation, as judged by the Investigator
  • Inadequate tumor material quality or quantity to support ctDNA analysis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Second Affiliated Hospital

Hangzhou, Zhejiang, China, 310009

Actively Recruiting

Loading map...

Research Team

H

HongFeng cao, Ph.D

CONTACT

R

Rui Liu, Ph.D

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation | DecenTrialz